Seth Harrison's Insider Trades & SAST Disclosures
Seth Harrison's most recent trade in Akero Therapeutics Inc was a trade of 26,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Seth Harrison.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akero Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2024 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 7,639 | 7,639 | - | - | Director Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,441 | 19,441 | - | - | Director Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 46.44 per share. | 30 Nov 2022 | 6,851 | 153,242 (0%) | 0% | 46.4 | 318,130 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 46.44 per share. | 30 Nov 2022 | 6,322 | 141,080 (0%) | 0% | 46.4 | 293,565 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 47.60 per share. | 30 Nov 2022 | 5,179 | 148,063 (0%) | 0% | 47.6 | 246,543 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 47.60 per share. | 30 Nov 2022 | 4,779 | 136,301 (0%) | 0% | 47.6 | 227,501 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 40.28 per share. | 28 Oct 2022 | 22,096 | 160,962 (0%) | 0% | 40.3 | 890,005 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 40.28 per share. | 28 Oct 2022 | 20,338 | 148,202 (0%) | 0% | 40.3 | 819,194 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 41.12 per share. | 28 Oct 2022 | 869 | 160,093 (0%) | 0% | 41.1 | 35,734 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 41.12 per share. | 28 Oct 2022 | 800 | 147,402 (0%) | 0% | 41.1 | 32,896 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 41.12 per share. | 25 Oct 2022 | 44,440 | 210,790 (0%) | 0% | 41.1 | 1,827,177 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 41.12 per share. | 25 Oct 2022 | 40,903 | 194,063 (0%) | 0% | 41.1 | 1,681,751 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 43.08 per share. | 25 Oct 2022 | 38,961 | 287,852 (1%) | 0% | 43.1 | 1,678,268 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 43.08 per share. | 25 Oct 2022 | 35,860 | 264,991 (0%) | 0% | 43.1 | 1,544,691 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 42.03 per share. | 25 Oct 2022 | 23,719 | 187,071 (0%) | 0% | 42.0 | 996,907 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 42.03 per share. | 25 Oct 2022 | 21,830 | 172,233 (0%) | 0% | 42.0 | 917,513 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 44.90 per share. | 25 Oct 2022 | 20,085 | 255,230 (0%) | 0% | 44.9 | 901,821 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 44.90 per share. | 25 Oct 2022 | 18,486 | 234,966 (0%) | 0% | 44.9 | 830,025 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 43.97 per share. | 25 Oct 2022 | 12,537 | 275,315 (0%) | 0% | 44.0 | 551,313 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 43.97 per share. | 25 Oct 2022 | 11,539 | 253,452 (0%) | 0% | 44.0 | 507,426 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 44.92 per share. | 25 Oct 2022 | 4,906 | 326,813 (1%) | 0% | 44.9 | 220,359 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 44.92 per share. | 25 Oct 2022 | 4,515 | 300,851 (1%) | 0% | 44.9 | 202,797 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 43.23 per share. | 25 Oct 2022 | 4,013 | 183,058 (0%) | 0% | 43.2 | 173,490 | Common Stock |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Sale of securities on an exchange or to another person at price $ 43.23 per share. | 25 Oct 2022 | 3,693 | 168,540 (0%) | 0% | 43.2 | 159,656 | Common Stock |
| Stoke Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 21,000 | 21,000 | - | - | Director Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Seth L. Harrison | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,650 | 11,650 | - | - | Director Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Seth Harrison | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 39.00 per share. | 24 Nov 2020 | 375,000 | 17,161,713 (52%) | 1% | 39 | 14,625,000 | Common Stock |
| Akero Therapeutics Inc | Seth Harrison | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 36.00 per share. | 10 Jul 2020 | 415,000 | 5,830,203 (20%) | 1% | 36 | 14,940,000 | Common Stock |
| Stoke Therapeutics Inc | Seth Harrison | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 14,777 | 14,777 | - | - | Director Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Seth Harrison | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges